New diabetes drug interaction study launched
NCT ID NCT07433062
First seen Feb 28, 2026 · Last updated May 15, 2026 · Updated 9 times
Summary
This study looks at how an experimental drug called AZD6793 changes the way metformin works in people with type 2 diabetes. About 28 adults on a stable dose of metformin will take AZD6793 or a placebo for a short time, and researchers will measure blood sugar levels. The goal is to understand if AZD6793 affects metformin's ability to control blood sugar.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Neuss, 41460, Germany
Conditions
Explore the condition pages connected to this study.